🔗 Share this article

The top legal official in Texas Ken Paxton is suing the makers of acetaminophen, asserting the firms hid alleged dangers that the drug posed to children's neurological development.

The lawsuit arrives four weeks after Donald Trump publicized an unsubstantiated connection between consuming acetaminophen - alternatively called paracetamol - throughout gestation and autism in young ones.

Paxton is taking legal action against J&J, which formerly manufactured the drug, the only pain reliever recommended for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he said they "deceived the public by making money from discomfort and promoting medication ignoring the potential hazards."

The company says there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening countless individuals to increase profits," the attorney general, from the Republican party, said.

The company stated officially that it was "very worried by the perpetuation of misinformation on the security of paracetamol and the potential impact that could have on the health of women and children in America."

On its official site, Kenvue also stated it had "continuously evaluated the pertinent research and there is lacking reliable evidence that shows a established connection between taking paracetamol and autism spectrum disorder."

Associations speaking for physicians and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in Tylenol - is one of the few options for expectant mothers to manage discomfort and elevated temperature, which can create serious health risks if not addressed.

"In multiple decades of research on the use of paracetamol in pregnancy, zero credible investigations has successfully concluded that the usage of paracetamol in any trimester of pregnancy leads to neurodevelopmental disorders in young ones," the organization said.

The lawsuit references latest statements from the former administration in asserting the drug is reportedly hazardous.

In recent weeks, the former president raised alarms from medical authorities when he instructed pregnant women to "resist strongly" not to use acetaminophen when sick.

Federal regulators then issued a notice that physicians should contemplate reducing the use of Tylenol, while also stating that "a direct connection" between the drug and autism in young ones has not been proven.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had vowed in April to conduct "extensive scientific investigation" that would identify the origin of autism spectrum disorder in a short period.

But specialists warned that discovering a unique factor of autism - believed by scientists to be the outcome of a complicated interplay of genetic and surrounding conditions - would prove challenging.

Autism spectrum disorder is a type of permanent neurological difference and condition that influences how individuals perceive and engage with the world, and is recognized using physician assessments.

In his court filing, the attorney general - a Trump ally who is seeking federal office - claims Kenvue and Johnson & Johnson "willfully ignored and tried to quiet the science" around acetaminophen and autism.

The case seeks to make the firms "remove any commercial messaging" that asserts acetaminophen is secure for pregnant women.

The court case mirrors the concerns of a group of mothers and fathers of young ones with autism and ADHD who took legal action against the makers of Tylenol in two years ago.

Judicial authorities threw out the case, declaring studies from the parents' expert witnesses was inconclusive.